333 related articles for article (PubMed ID: 12438234)
21. Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer.
Artale S; Sartore-Bianchi A; Veronese SM; Gambi V; Sarnataro CS; Gambacorta M; Lauricella C; Siena S
J Clin Oncol; 2008 Sep; 26(25):4217-9. PubMed ID: 18757341
[No Abstract] [Full Text] [Related]
22. Correlation of polypoid colorectal adenocarcinoma with pre-existing adenomatous polyps and KRAS mutation.
Chen H; Lefferts JA; Schwab MC; Suriawinata AA; Tsongalis GJ
Cancer Genet; 2011 May; 204(5):245-51. PubMed ID: 21665177
[TBL] [Abstract][Full Text] [Related]
23. Clinical subtypes and molecular characteristics of serrated polyposis syndrome.
Guarinos C; Sánchez-Fortún C; Rodríguez-Soler M; Pérez-Carbonell L; Egoavil C; Juárez M; Serradesanferm A; Bujanda L; Fernández-Bañares F; Cubiella J; de-Castro L; Guerra A; Aguirre E; Herreros-de-Tejada A; Bessa X; Herráiz M; Marín-Gabriel JC; Balmaña J; Cuatrecasas M; Balaguer F; Castells A; Soto JL; Alenda C; Payá A; Jover R
Clin Gastroenterol Hepatol; 2013 Jun; 11(6):705-11; quiz e46. PubMed ID: 23376323
[TBL] [Abstract][Full Text] [Related]
24. [BRAF mutation in colorectal serrated lesions].
Zhou ZY; Han Y; Wang LP
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3411-4. PubMed ID: 19159571
[TBL] [Abstract][Full Text] [Related]
25. The serrated pathway to colorectal carcinoma: current concepts and challenges.
Bettington M; Walker N; Clouston A; Brown I; Leggett B; Whitehall V
Histopathology; 2013 Feb; 62(3):367-86. PubMed ID: 23339363
[TBL] [Abstract][Full Text] [Related]
26. A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix.
Yantiss RK; Panczykowski A; Misdraji J; Hahn HP; Odze RD; Rennert H; Chen YT
Am J Surg Pathol; 2007 Nov; 31(11):1742-53. PubMed ID: 18059232
[TBL] [Abstract][Full Text] [Related]
27. The histopathology of BRAF-V600E-mutated lung adenocarcinoma.
Yousem SA; Nikiforova M; Nikiforov Y
Am J Surg Pathol; 2008 Sep; 32(9):1317-21. PubMed ID: 18636014
[TBL] [Abstract][Full Text] [Related]
28. [Clinical-pathological features and gene profile in colorectal cancer].
Perazzo F; Piaggio F; Krupitzki H; García A; Avagnina A; Elsner B; Denninghoff V
Medicina (B Aires); 2013; 73(5):417-22. PubMed ID: 24152396
[TBL] [Abstract][Full Text] [Related]
29. Tubular adenomas with minor villous changes show molecular features characteristic of tubulovillous adenomas.
Ishii T; Notohara K; Umapathy A; Mallitt KA; Chikuba H; Moritani Y; Tanaka N; Rosty C; Matsubara N; Jass J; Leggett B; Whitehall V
Am J Surg Pathol; 2011 Feb; 35(2):212-20. PubMed ID: 21263241
[TBL] [Abstract][Full Text] [Related]
30. BRAF V600E Mutations in Endometrial Adenocarcinoma.
He M; Breese V; Hang S; Zhang C; Xiong J; Jackson C
Diagn Mol Pathol; 2013 Mar; 22(1):35-40. PubMed ID: 23370429
[TBL] [Abstract][Full Text] [Related]
31. Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study.
Naguib A; Mitrou PN; Gay LJ; Cooke JC; Luben RN; Ball RY; McTaggart A; Arends MJ; Rodwell SA
BMC Cancer; 2010 Mar; 10():99. PubMed ID: 20233436
[TBL] [Abstract][Full Text] [Related]
32. Identification of frequent BRAF copy number gain and alterations of RAF genes in Chinese prostate cancer.
Ren G; Liu X; Mao X; Zhang Y; Stankiewicz E; Hylands L; Song R; Berney DM; Clark J; Cooper C; Lu YJ
Genes Chromosomes Cancer; 2012 Nov; 51(11):1014-23. PubMed ID: 22833462
[TBL] [Abstract][Full Text] [Related]
33. High nuclear expression of phosphorylated extracellular signal-regulated kinase in tumor cells in colorectal glands is associated with poor outcome in colorectal cancer.
Tai CJ; Lee CH; Chen HC; Wang HK; Jiang MC; Su TC; Shen KH; Lin SH; Yeh CM; Chen CJ; Yeh KT; Chang CC
Ann Diagn Pathol; 2013 Apr; 17(2):165-71. PubMed ID: 23183114
[TBL] [Abstract][Full Text] [Related]
34. Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway.
Nosho K; Igarashi H; Nojima M; Ito M; Maruyama R; Yoshii S; Naito T; Sukawa Y; Mikami M; Sumioka W; Yamamoto E; Kurokawa S; Adachi Y; Takahashi H; Okuda H; Kusumi T; Hosokawa M; Fujita M; Hasegawa T; Okita K; Hirata K; Suzuki H; Yamamoto H; Shinomura Y
Carcinogenesis; 2014 Apr; 35(4):776-83. PubMed ID: 24242331
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive procedural approach to genotyping KRAS and BRAF from paraffin embedded tissues for diagnostic purposes.
Palmirotta R; Ludovici G; De Marchis ML; Leone B; Formica V; Ettorre GM; Cavaliere F; Della-Morte D; Ferroni P; Roselli M; Guadagni F
In Vivo; 2012; 26(4):537-47. PubMed ID: 22773565
[TBL] [Abstract][Full Text] [Related]
36. Lack of BRAF activating mutations in prostate adenocarcinoma: a study of 93 cases.
Liu T; Willmore-Payne C; Layfield LJ; Holden JA
Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):121-5. PubMed ID: 18987552
[TBL] [Abstract][Full Text] [Related]
37. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
[TBL] [Abstract][Full Text] [Related]
38. Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma.
Sekine S; Ogawa R; Oshiro T; Kanemitsu Y; Taniguchi H; Kushima R; Kanai Y
Genes Chromosomes Cancer; 2014 Apr; 53(4):366-72. PubMed ID: 24470207
[TBL] [Abstract][Full Text] [Related]
39. Clinical-pathological correlation of K-Ras mutation and ERK phosphorylation in colorectal cancer.
Tai CJ; Chang CC; Jiang MC; Yeh CM; Su TC; Wu PR; Chen CJ; Yeh KT; Lin SH; Chen HC
Pol J Pathol; 2012 Jun; 63(2):93-100. PubMed ID: 22864777
[TBL] [Abstract][Full Text] [Related]
40. BRAF mutations in melanoma and colorectal cancer: a single oncogenic mutation with different tumour phenotypes and clinical implications.
Sclafani F; Gullo G; Sheahan K; Crown J
Crit Rev Oncol Hematol; 2013 Jul; 87(1):55-68. PubMed ID: 23246082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
